Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
QuintilesIMS
Cerilliant
Argus Health
AstraZeneca
Colorcon
Cantor Fitzgerald
Harvard Business School
Julphar

Generated: November 21, 2018

DrugPatentWatch Database Preview

Drugs in Development Information for Ifetroban

« Back to Dashboard

US Patents for Ifetroban

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Ifetroban ➤ Try a Free Trial 7-oxabicycloheptyl substituted heterocyclic amide or ester prostaglandin analogs useful in the treatment of thrombotic and vasospastic disease E. R. Squibb & Sons, Inc. (Princeton, NJ) ➤ Try a Free Trial
Ifetroban ➤ Try a Free Trial 7-Oxabicycloheptyl substituted heterocyclic amide or ester prostaglandin analogs useful in the treatment of thrombotic and vasospastic disease E. R. Squibb & Sons, Inc. (Princeton, NJ) ➤ Try a Free Trial
Ifetroban ➤ Try a Free Trial Method for preparing 7-oxabicycloheptyl substituted heterocyclic amide prostaglandin analogs useful in the treatment of thrombotic and vasospastic disease E. R. Squibb & Sons, Inc. (Princeton, NJ) ➤ Try a Free Trial
Ifetroban ➤ Try a Free Trial Method for preparing 7-oxabicycloheptyl substituted bromooxazole amide prostaglandin analog intermediates useful in the preparation of anti-thrombotic and anti-vasospastic compounds E. R. Squibb & Sons, Inc. (Princeton, NJ) ➤ Try a Free Trial
Ifetroban ➤ Try a Free Trial Method for preparing 7-oxabicycloheptyl substituted oxazole amide prostaglandin analog intermediates useful in the preparation of anti-thrombotic and anti-vasospastic compounds Bristol-Myers Squibb Company (Princeton, NJ) ➤ Try a Free Trial
Ifetroban ➤ Try a Free Trial Method for preparing a benzaldehyde intermediate Bristol-Myers Squibb Company (Princeton, NJ) ➤ Try a Free Trial
Ifetroban ➤ Try a Free Trial Method of preparing 7-oxabicycloheptyl substituted heterocyclic amide prostaglandin analogs useful in the treatment of thrombotic and vasospastic disease E. R. Squibb & Sons, Inc. (Princeton, NJ) ➤ Try a Free Trial
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for Ifetroban

Drugname Country Document Number Estimated Expiration Related US Patent
Ifetroban Austria 119903 2009-04-03 ➤ Try a Free Trial
Ifetroban Australia 4729089 2008-12-23 ➤ Try a Free Trial
Ifetroban Australia 5206490 2008-12-23 ➤ Try a Free Trial
Ifetroban Australia 617569 2008-12-23 ➤ Try a Free Trial
Ifetroban Australia 632797 2008-12-23 ➤ Try a Free Trial
Ifetroban Canada 2006355 2008-12-23 ➤ Try a Free Trial
Ifetroban Canada 2012267 2008-12-23 ➤ Try a Free Trial
Drugname Country Document Number Estimated Expiration Related US Patent

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
AstraZeneca
UBS
Teva
Dow
McKesson
Baxter
Mallinckrodt
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.